Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06874608 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis

Study acronym: JIA-ED
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 13, 2025 (before its estimated May 15, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The JIA-ED study is a pilot project. Based on experience in another inflammatory disease, a 4-week period was extrapolated as sufficient to assess the effectiveness of the experimental intervention. This observation is supported by literature data showing that, halfway through phase I of the CDED (Crohn Diseasse Exclusion Diet), it is already possible to identify a subset of patients with Crohn's disease who are responsive to the dietary treatment and who also have a higher likelihood of achieving clinical remission by the end of the first phase of the diet itself.
Trial Details
NCT Number NCT06874608
Lead Sponsor Meyer Children's Hospital IRCCS
Conditions
(from sponsor)		 Juvenile Idiopathic Arthritis (JIA)
Related terms Arthritis, Juvenile
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov